Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-utility analysis in schizophrenia.

A G Awad1, L P Voruganti

  • 1Clarke Institute of Psychiatry, University of Toronto, Ontario, Canada.

The Journal of Clinical Psychiatry
|March 12, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient satisfaction and acceptability of long-term treatment with quetiapine.

International journal of psychiatry in clinical practice·2014
Same author

Origin oriented management of inverted papilloma of the frontal sinus.

Rhinology·2012
Same author

Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) study.

Schizophrenia research·2007
Same author

Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine.

Schizophrenia research·2007
Same author

An innovative approach to clinical communication in schizophrenia: the approaches to schizophrenia communication checklists.

CNS spectrums·2005
Same author

Brain imaging research on subjective responses to psychotropic drugs.

Acta psychiatrica Scandinavica. Supplementum·2005
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Estimating quality of life is crucial for schizophrenia pharmacoeconomics. Utility analysis shows promise for assessing patient preferences, despite challenges in defining and measuring quality of life.

Area of Science:

  • Psychiatry
  • Health Economics
  • Psychometrics

Background:

  • Quality of life (QoL) estimation is vital for schizophrenia pharmacoeconomics.
  • New antipsychotics offer improved side effect profiles but at higher costs.
  • Inconsistent QoL definitions and inappropriate scales hinder accurate measurement.

Purpose of the Study:

  • To examine the feasibility of utility analysis in schizophrenia patients.
  • To identify challenges in QoL and utility analysis for this population.

Main Methods:

  • Utility analysis was performed with schizophrenia patients.
  • Initial observations were collected from the study.

Main Results:

  • Utility analysis is a feasible method for assessing QoL in schizophrenia.

Related Experiment Videos

  • Challenges remain in the consistent definition and measurement of QoL.

    • Conclusions:

    • Utility analysis offers a valuable approach to QoL assessment in schizophrenia.
    • Further research is needed to refine methods for QoL and utility analysis in this population.